Weis names new VP pharmacy

Douglas will oversee the day-to-day merchandising, operation and management of Weis Markets’ 122 pharmacies and also will direct the company’s lifestyle initiatives’ team, which focuses on health-and-wellness issues. Douglas will report to Kurt Schertle, SVP sales and merchandising.

Douglas was a 27-year Walgreens veteran, where he was VP transforming community practice.

APhA releases pharmacy management guide

WASHINGTON — The American Pharmacists Association has released a new information resource for pharmacists and pharmacy students about pharmacy management, the group said.

The APhA announced Wednesday the release of "Getting Started as a Pharmacy Manager," a 171-page book for new and aspiring pharmacy managers about handling such managing issues as managing people, adhering to laws and regulations, and running a business.

The book was written by American Association of Colleges of Pharmacy director of professional alliance development Lynette Bradley-Baker. It is available from the APhA’s website for $31.50, or $25 for organization members.

The APhA also announced the publication of the 17th edition of its guide to non-prescription drugs, "Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care." The new edition, which sells for $179.95, or $144 for APhA members, has a new chapter that focuses on self-care of diabetes and other disorders and two new appendices that cover safe use of non-prescription drugs, supplements and natural products during pregnancy, as well as vaccine information.

ALEXANDRIA, Va. — The National Association of Chain Drug Stores has announced that election analyst and University of Virginia professor Larry Sabato will address attendees at the 2012 NACDS Annual Meeting on April 21 to 24 in Palm Beach, Fla.

Sabato will offer remarks to NACDS Annual Meeting attendees during the business program on Sunday, April 22.

“During this presidential and congressional election year, it is only fitting to have Larry Sabato address the attendees of the NACDS Annual Meeting,” NACDS president and CEO Steve Anderson said. “Larry’s astute election forecasting and political analyses are really second to none. We look forward to hearing his insights and predictions for the upcoming political season.”

Sabato is the founder and head of the University of Virginia’s Center for Politics, and is the author of more than 20 book and numerous essays on politics. He also spearheads “Sabato’s Crystal Ball,” a website providing detailed and updated analysis for elections nationwide. Sabato has received multiple awards and accolades including UVA’s highest honor, the Thomas Jefferson Award, has been a guest scholar at the Brookings Institution, Oxford University and Cambridge University.

He also has served on many national and state commissions, including the National Commission for the Renewal of American Democracy and the Senate Campaign Finance Reform Panel. Sabato has appeared on various news programs and is a regular contributor to National Public Radio.

RELATED NEWS

The Food and Drug Administration has approved a generic of Hoffman-La Roche’s Tamiflu (oseltamivir phosphate) capsules from Lupin. The company’s generic will be available in 30-, 45- and 75-mg dosage strengths.
The product is inficated to treat acute, uncomplicated influenza A and B in patients 2 weeks of age and older, as well as to prevent influenza A and B in patients 1 year old and older. The drug had U.S. sales of roughly $467.8 million for the 12 months ended October 2017, according to IQVIA data.

Behavioral health pharmacy and telepsychiatry company Genoa, a QoL Healthcare Company, has reached a big number with its remote psychiatry offering. The Tukwila, Wash.-based company announced Tuesday that it had facilitated more than 100,000 telepsych consultations on its video conferencing platform.
Genoa attributes the milestone to its recent buildup of its telepsychiatry operations, which grew to include 35 in 2017 from 20 at the start of the year, and included 250 providers. In 2017, the company grew to serve more than 2,500 patients per week.

This year's flu continues to be Texas big, according to the Walgreens Flu Index released Wednesday, as the top 10 communities experiencing the greatest amount of flu incidence were all located in the Lone Star State for the week ended Jan. 6.
Iowa, Idaho and Arkansas rank behind Texas in terms of flu activity. And Montana, Idaho and Iowa ranked highest among states experiencing flu activity gains.

Amneal Biosciences has launched its generic of Otsuka’s Busulfex (busulfan injection, 6 mg/ml). The product is indicated to treat chronic myelogenous leukemia.
Amneal said that its generic is available in cartons of eight single-dose vials, each of which contains 60 mg of the drug in a 10-ml clear sterile solution. The product is made without natural rubber, latex, gluten or preservatives, Amneal said.
The drug had U.S. sales of roughly $80 million for the 12 months ended October 2017, according to data from IQVIA.

Amneal Pharmaceuticals has launched sevelamer carbonate tablets, 800 mg, in 270-count bottles. This generic from the Bridgewater, N.J.-based company is an AB-rated therapeutic equivalent to Renvela.
Amneal also launched five other products in addition to sevelamer carbonate:

Forgotten Password

Registration complete

REGISTER

USERNAME *

Spaces are allowed; punctuation is not allowed except for periods, hyphens, and underscores.

E-MAIL ADDRESS *

A valid e-mail address. All e-mails from the system will be sent to this address. The e-mail address is not made public and will only be used if you wish to receive a new password or wish to receive certain news or notifications by e-mail.

Password *

Confirm Password *

Please choose a password for your account; it must be 8 - 30 characters. .

First Name *

Last Name *

Company Name *

Job Title *

ZIP *

Are you a *

Retailer or Healthcare professional

Non-Retailer

How many stores do you operate?: *

Which best describes the business/industry you work in?: *

Which best describes your job title?: *

Please select the newsletters you would like to subscribe to

DSN A.M.
Daily news stories covering the retail drug industry

Breaking News
First-to-the-market with developing stories in the industry